LobbyingThe Children's Hospital of Philadelphia lobbying by quarter
The Children's Hospital of Philadelphia's latest lobbying report covers Q2 2026, at $350K. The four quarters Q4 2025–Q3 2026 total $1.1M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
The Children's Hospital of Philadelphia
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.1M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $200K | 2 |
| Q1 2023 | $150K | 2 |
| Q2 2023 | $160K | 2 |
| Q3 2023 | $160K | 2 |
| Q4 2023 | $220K | 2 |
| Q1 2024 | $160K | 2 |
| Q2 2024 | $180K | 2 |
| Q3 2024 | $180K | 2 |
| Q4 2024 | $240K | 2 |
| Q1 2025 | $260K | 3 |
| Q2 2025 | $410K | 3 |
| Q3 2025 | $330K | 3 |
| Q4 2025 | $410K | 3 |
| Q1 2026 | $340K | 3 |
| Q2 2026 | $350K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$2.2M · 33 reports
- Budget and appropriations$1.5M · 26 reports
- Defense$66.7K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE32 reports
- HOUSE OF REPRESENTATIVES31 reports
- Centers For Medicare and Medicaid Services (CMS)14 reports
- Health & Human Services, Dept of (HHS)7 reports
- Executive Office of the President (EOP)3 reports
- Centers For Disease Control & Prevention (CDC)2 reports
- Food & Drug Administration (FDA)2 reports
- Health Resources & Services Administration (HRSA)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseThe Children's Hospital of Philadelphia | $2.6M | 15 quarters |
| BGR Government Affairs | $660K | 6 quarters |
| Arentfox Schiff | $460K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHRIS KELLY | Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn | Q2 2026 |
| DAVID URBAN | COS Sen. Specter; 11th Chair of the Ame. Battle Monuments Comm.; USMA Board of Visitors | Q2 2026 |
| JAMES WILLIAMS | Special Assist. to the Pres., WH Domestic Policy Council, 2019-2021; Economist, WH Council of Economic Advisors, 2017-2019 | Q2 2026 |
| JOEL D. BAILEY | COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall | Q2 2026 |
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz | Q2 2026 |
| ROBB WALTON | Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes | Q2 2026 |
| MARVIN BENITO FIGUEROA | COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White House | Q1 2026 |
| ELIZABETH HORNER | Chief Counsel, Senate Environment and Public Works Committee (2021-2024), Senior Counsel, Senate Environment and Public Works Committee (2018-2021), Counsel, Senate Environment and Public Works Committee (2017-2018) | Q4 2024 |
| KATHERINE KRAMER | Intern/Fellow, Rep. Emanuel Cleaver (2017-2019) | Q4 2024 |
| STARSHINE CHUN | Executive Assistant/Deputy Scheduler, Sen. Brian Schatz (2021-2023) | Q4 2024 |
| BYRON DORGAN | U.S. Senator (1992-2011) | Q2 2023 |
| KELSEY GRISWOLD-BERGER | Leg Asst, Sen. Burr (2021-2023); Leg Dir, Rep. C. Smith (2018-2021); Leg Dir, Rep. Pittenger (2018); Leg Dir, Rep. Blum (2017-2018); Leg Asst, Rep. Perry (2015-2017); Leg Asst (2014-2015), Leg Corr/Press Asst (2011-2014), Staff Asst (2011), Rep. Reed | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | BGR Government Affairs | $120K |
| 07/20for Q2 | In-house | $230K |
| 07/19for Q2 | Arentfox Schiff | Under $5,000 |
| 04/20for Q1 | In-house | $220K |
| 04/20for Q1 | BGR Government Affairs | $120K |
| 04/17for Q1 | Arentfox Schiff | Under $5,000 |
| 01/20for Q4 2025 | BGR Government Affairs | $120K |
| 01/20for Q4 2025 | Arentfox Schiff | Under $5,000 |
| 01/20for Q4 2025 | In-house | $290K |
| 01/12for Q1 | BGR Government Affairs | Under $5,000 |
| 01/12for Q4 2025 | BGR Government Affairs | $120K |
| 25/10/20for Q3 2025 | BGR Government Affairs | $120K |
| 25/10/17for Q3 2025 | In-house | $210K |
| 25/10/16for Q3 2025 | Arentfox Schiff | Under $5,000 |
| 25/07/21for Q2 2025 | Arentfox Schiff | $30K |
| 25/07/21for Q2 2025 | BGR Government Affairs | $120K |
| 25/07/18for Q2 2025 | In-house | $260K |
| 25/04/23for Q4 2024 | Arentfox Schiff | $50K |
| 25/04/21for Q1 2025 | BGR Government Affairs | $60K |
| 25/04/20for Q1 2025 | In-house | $150K |